Advertisement

Topics

New England BioLabs Incorporated Company Profile

13:01 EST 17th December 2018 | BioPortfolio

Molecular Biology Restriction Endonucleases
GPS™-1 Genome Priming System
GPS™-M Mutagenesis System
IMPACT™ -CN

Signal Transduction
Phospho-specific Antibody Samplers
Akt Kinase Assay Kit
Acetylated-Lysine Antibody
Phospho-Threonine Prolisignal translation.

Location

32 Tozer Road
Beverley
MA
01915
United States of America

Contact

Phone: 508 927 5054
Fax: 508 921 1350


News Articles [560 Associated News Articles listed on BioPortfolio]

Avacta Group signs licensing deal with New England Biolabs (NEB)

Alastair Smith, chief executive of Avacta Group Plc (LON:AVCT),  discusses with Proactive Investors a licensing deal they've signed with New England Biolabs (NEB), an enzyme discovery and produ...

New England Biolabs® Scientists Push the Limits of Golden Gate Assembly

The post New England Biolabs® Scientists Push the Limits of Golden Gate Assembly appeared first on SynBioBeta.

Cleveland BioLabs, Inc: Cleveland Biolabs Announces Formation and Financing of an Anti-Aging Joint Venture

Goal is to Develop and Commercialize Entolimod and Other Compounds for Anti-aging Applications BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported for...

Amgen and MBC Biolabs Announce Winners of the Amgen Golden Ticket

Two Biotherapeutic Companies Receive Lab Space and Other Benefits at Bay Area Life Sciences IncubatorTHOUSAND OAKS, Calif. and SAN FRANCISCO (June 29, 2018) - Amgen (NASDAQ:AMGN) and MBC...

Avacta rises as it secures licensing deal with New England Biolabs for Affimer technology

The biotechnology firm said it had been collaborating with NEB to develop Affimers to combine with NEB’s reagents (a substance used for chemical analysis)

Cleveland BioLabs, Inc: Cleveland Biolabs Reports Third Quarter 2018 Financial Results and Development Progress

BUFFALO, NY / ACCESSWIRE / November 14, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the third quarter ended September 30, 2018. Cleve...

Avacta Agrees Affimer Reagent Licensing Deal with New England Biolab

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a commercial license with New England Biolabs® (NEB®) (Ipswi...

Avacta’s Affirmer tech gains traction as it clinches deal with “very high quality partner”

The deal with New England Biolabs, signed in October, is expected to secure six-figure royalty sums as soon as next year

PubMed Articles [1135 Associated PubMed Articles listed on BioPortfolio]

Organisation and delivery of liaison psychiatry services in general hospitals in England: results of a national survey.

To describe the current provision of hospital-based liaison psychiatry services in England, and to determine different models of liaison service that are currently operating in England.

Inequalities in hip fracture incidence are greatest in the North of England: regional analysis of the effects of social deprivation on hip fracture incidence across England.

Hip fracture risk varies by geography and by levels of deprivation. We examined the effect of local area-level deprivation on hip fracture incidence across nine regions in England, using 14 years of h...

Time to rethink surgeon-specific outcome data for Colorectal Surgeons in England: A Short Report of cross-sectional data.

Since 2013, individual surgeon and NHS Trusts outcomes following elective colorectal cancer surgery have been in the public domain in England. The 90-day operative mortality rates following colorectal...

Equal North: how can we reduce health inequalities in the North of England? A prioritization exercise with researchers, policymakers and practitioners.

The Equal North network was developed to take forward the implications of the Due North report of the Independent Inquiry into Health Equity. The aim of this exercise was to identify how to reduce hea...

Normalization of Plus Size and the Danger of Unseen Overweight and Obesity in England.

This study aimed to investigate trends and sociodemographic factors underlying weight misperception in adults with overweight and obesity in England.

Clinical Trials [105 Associated Clinical Trials listed on BioPortfolio]

Improving the Management of Drug Resistant Tuberculosis in the UK

The 'rising tide' of antimicrobial resistance is a source of concern across most infectious diseases. In the UK, for example, 6.8% of the ~8,500 tuberculosis patients seen in 2012 were res...

Comparison of I-Gel to the Laryngeal Mask Airway

The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion,...

NHS AAA Screening Programme Data Linkage With HES and ONS Datasets

An abdominal aortic aneurysm (AAA) is a dilation of the aorta, defined as an aortic diameter of ≥3cm. It is a significant cause of death internationally and in England each year causes c...

Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England Smoking Cessation and Reduction in Pregnancy Trial (SCRIPT)

Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant w...

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

RATIONALE: Gathering information about genetic and environmental factors from patients with lung cancer and their partners and first-degree relatives may help doctors learn more about the ...

Companies [283 Associated Companies listed on BioPortfolio]

New England Biolabs, Inc.

Torrey Pines Biolabs

Chemokine.com is a product line from Torrey Pines Biolabs, Inc. established in San Diego, California, have been moved to Houston, Texas since January 2001. Torrey Pines Biolabs is an emerging biotechn...

Pacific BioLabs

Pacific BioLabs is an independent laboratory with over 25 years experience providing cGMP/GLP testing services to companies in the Pharmaceutical, Biopharm, Medical Device, Diagnostic and OECD/EPA reg...

New England BioLabs Incorporated

Molecular Biology Restriction EndonucleasesGPS™-1 Genome Priming SystemGPS™-M Mutagenesis SystemIMPACT™ -CN Signal Transduction Phospho-specific Antibody SamplersAkt Kinase Assay KitAcetylat...

Delta Biolabs, LLC

Establish Delta Biolabs as the premier source of technically superior antibodies for the research community.In our endeavor to provide the highest quality reagents we will adhere to four values:100% C...

More Information about "New England BioLabs Incorporated" on BioPortfolio

We have published hundreds of New England BioLabs Incorporated news stories on BioPortfolio along with dozens of New England BioLabs Incorporated Clinical Trials and PubMed Articles about New England BioLabs Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of New England BioLabs Incorporated Companies in our database. You can also find out about relevant New England BioLabs Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record